tiprankstipranks
Novo Nordisk (GB:0QIU)
LSE:0QIU

Novo Nordisk Stock Forecast & Price Target

7 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Moderate Buy
13Ratings
8 Buy
3 Hold
2 Sell
Based on 13 analysts giving stock ratings to
Novo
Nordisk
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0QIU Stock Price Prediction

Average Price Target

kr824.00
▲(11.26% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Novo Nordisk in the last 3 months. The average price target is kr824.00 with a high forecast of kr1,000.00 and a low forecast of kr392.00. The average price target represents a 11.26% change from the last price of kr740.58.
Highest Price Targetkr1,000.00Average Price Targetkr824.00Lowest Price Targetkr392.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Goldman Sachs
kr975.00
Buy
31.65%
Upside
Reiterated
Morgan Stanley
kr915.00
Buy
23.55%
Upside
Upgraded
Novo Nordisk upgraded to Overweight from Equal Weight at Morgan StanleyNovo Nordisk upgraded to Overweight from Equal Weight at Morgan Stanley
Citigroup
kr925.00
Buy
24.90%
Upside
Reiterated
Citi Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)Citi analyst Peter Verdult reiterated a Buy rating and DKK925.00 price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO).
BNP Paribas
kr750.00
Hold
1.27%
Upside
Upgraded
Novo Nordisk upgraded to Neutral from Underperform at Exane BNP ParibasNovo Nordisk upgraded to Neutral from Underperform at Exane BNP Paribas
Guggenheim
kr896.00
Buy
20.99%
Upside
Upgraded
Novo Nordisk upgraded to Buy from Neutral at GuggenheimNovo Nordisk upgraded to Buy from Neutral at Guggenheim
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTYXVentyx Biosciences
PRVAPrivia Health Group
RXDXPrometheus Biosciences
IMCRImmunocore Holdings
SKINBeauty Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

0QIU Stock Forecast FAQ

What is GB:0QIU’s average 12-month price target, according to analysts?
Based on analyst ratings, Novo Nordisk’s 12-month average price target is kr824.00.
    What is GB:0QIU’s upside potential, based on the analysts’ average price target?
    Novo Nordisk has 11.26% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GB:0QIU a Buy, Sell or Hold?
          Novo Nordisk has a conensus rating of Moderate Buy which is based on 8 buy ratings, 3 hold ratings and 2 sell ratings.
            What is Novo Nordisk’s price target?
            The average price target for Novo Nordisk is kr824.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is kr1,000.00 ,the lowest forecast is kr392.00. The average price target represents 11.26% Increase from the current price of kr740.575.
              What do analysts say about Novo Nordisk?
              Novo Nordisk’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis